Martha Thomson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martha Thomson has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
A. Al-Nakkas
4 shared publicationsA.A. Conti
4 shared publicationsAdel K. Ayed
4 shared publicationsAdile Çevikbaş
4 shared publications- Ahmet Kocakusak
Department of General Surgery, Haseki Training and Research Hospital, İstanbul, Turkey
4 shared publications Ahmet Tarlaci
4 shared publications
Latest Publications
- 1 December 2017
- Published by Elsevier in Pathophysiology
- Vol. 24 (4) , 317-325
Garlic extract increases non-clipped kidney tubular natriuresis and diuresis in the 2-kidney, 1-clip rat model: Significance in hypertension
- 1 December 2017
- Published by Elsevier in Pathophysiology
- Vol. 24 (4) , 317-325
Garlic extract increases non-clipped kidney tubular natriuresis and diuresis in the 2-kidney, 1-clip rat model: Significance in hypertension
- Open Access
- 1 August 2017
- Published by IMR Press in International Journal of Pharmacology
- Vol. 13 (6) , 593-602
Oral Intake of Aged Garlic Extract (AGE) Ameliorates Oxidative Stress and Other Streptozotocin-induced Diabetic Complications in Rats
- 1 August 2017
- Published by IMR Press in International Journal of Pharmacology
- Vol. 13 (6) , 593-602
Open AccessOral Intake of Aged Garlic Extract (AGE) Ameliorates Oxidative Stress and Other Streptozotocin-induced Diabetic Complications in Rats
- Open Access
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 8142394
Garlic Attenuates Plasma and Kidney ACE‐1 and AngII Modulations in Early Streptozotocin‐Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications
Raw garlic aqueous extract (GE) has ameliorative actions on the renin‐angiotensin system in type‐1 diabetes mellitus (DM); however its effects on plasma and kidney angiotensin I converting enzyme type‐1 (ACE‐1) and angiotensin II (AngII) require further elucidation. This study investigated the effect of GE on plasma and kidney ACE‐1 and AngII concentrations and in relation to systemic and renal clearance indicators significant to blood pressure (BP) homeostasis in early streptozotocin‐ (STZ‐) induced type‐1 DM. Normal rats (n = 10) received 0.5 mL normal saline (NR/NS), diabetic rats (n = 10) received 0.5 mL NS (DR/NS), and treated diabetic rats (n = 10) received 50 mg/0.1 mL/100 g body weight GE (DR/GE) as daily intraperitoneal injections for 8 weeks. Compared to NR/NS, DR/NS showed a significant increase in plasma ACE‐1 and AngII and conversely a decrease in kidney ACE‐1 and AngII. These changes were associated with an increase in BP and clearance functions. Alternatively and compared to DR/NS, DR/GE showed normalization or attenuation in plasma and kidney ACE‐1 and AngII. These GE induced rectifications were associated with moderation in BP elevation and renal clearance functions. Garlic attenuates modulations in plasma and kidney ACE‐1 and AngII, in addition to BP and renal clearance function in type‐1 DM.
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 8142394
Open AccessGarlic Attenuates Plasma and Kidney ACE‐1 and AngII Modulations in Early Streptozotocin‐Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications
Raw garlic aqueous extract (GE) has ameliorative actions on the renin‐angiotensin system in type‐1 diabetes mellitus (DM); however its effects on plasma and kidney angiotensin I converting enzyme type‐1 (ACE‐1) and angiotensin II (AngII) require further elucidation. This study investigated the effect of GE on plasma and kidney ACE‐1 and AngII concentrations and in relation to systemic and renal clearance indicators significant to blood pressure (BP) homeostasis in early streptozotocin‐ (STZ‐) induced type‐1 DM. Normal rats (n = 10) received 0.5 mL normal saline (NR/NS), diabetic rats (n = 10) received 0.5 mL NS (DR/NS), and treated diabetic rats (n = 10) received 50 mg/0.1 mL/100 g body weight GE (DR/GE) as daily intraperitoneal injections for 8 weeks. Compared to NR/NS, DR/NS showed a significant increase in plasma ACE‐1 and AngII and conversely a decrease in kidney ACE‐1 and AngII. These changes were associated with an increase in BP and clearance functions. Alternatively and compared to DR/NS, DR/GE showed normalization or attenuation in plasma and kidney ACE‐1 and AngII. These GE induced rectifications were associated with moderation in BP elevation and renal clearance functions. Garlic attenuates modulations in plasma and kidney ACE‐1 and AngII, in addition to BP and renal clearance function in type‐1 DM.
- Open Access
- 1 December 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 16 (1) , 17
Anti-diabetic and anti-oxidant potential of aged garlic extract (AGE) in streptozotocin-induced diabetic rats
Although aged garlic extract (AGE) shares some active components with fresh garlic and in spite of its palatability and milder side effects, the anti-diabetic and related anti-oxidant properties of AGE have not been investigated extensively, and the reported findings are inconsistent. This study investigated the anti-diabetic effects of 3 incremental doses of AGE in streptozotocin (STZ)-induced diabetic rats (fasting blood sugar > 20 mM). Diabetic rats were divided into a control diabetic group (CD) and AGE-treated diabetic group (AGE-D). The AGE-D was divided into 3 groups and accordingly treated with AGE i.p. at 100, 300 and 600 mg/kg daily for 8 weeks. A control normal group (CN) was also included for reference. Compared to the CN group, the CD group showed significant loss of body weight (over 50 %); and decreased serum insulin concentration (10 fold) and total anti-oxidant level and catalase activity (45–70 %) in serum, kidney and liver. Conversely, the CD rats had an elevated blood glucose (nearly 4 fold), serum cholesterol (nearly 2 fold) and triglycerides (>2 fold), erythrocyte glycated hemoglobin (GHb, 3 fold) and kidney and liver lipid peroxidation (MDA levels). Treatment with AGE positively reversed the diabetic changes in the targeted parameters to levels significantly lower than those measured in the CD group and the degrees of attenuation were almost dose dependent especially with the two higher doses. AGE exhibits a dose-dependent ameliorative action on indicators of diabetes in STZ-induced diabetic rats.
- 1 December 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 16 (1) , 17
Open AccessAnti-diabetic and anti-oxidant potential of aged garlic extract (AGE) in streptozotocin-induced diabetic rats
Although aged garlic extract (AGE) shares some active components with fresh garlic and in spite of its palatability and milder side effects, the anti-diabetic and related anti-oxidant properties of AGE have not been investigated extensively, and the reported findings are inconsistent. This study investigated the anti-diabetic effects of 3 incremental doses of AGE in streptozotocin (STZ)-induced diabetic rats (fasting blood sugar > 20 mM). Diabetic rats were divided into a control diabetic group (CD) and AGE-treated diabetic group (AGE-D). The AGE-D was divided into 3 groups and accordingly treated with AGE i.p. at 100, 300 and 600 mg/kg daily for 8 weeks. A control normal group (CN) was also included for reference. Compared to the CN group, the CD group showed significant loss of body weight (over 50 %); and decreased serum insulin concentration (10 fold) and total anti-oxidant level and catalase activity (45–70 %) in serum, kidney and liver. Conversely, the CD rats had an elevated blood glucose (nearly 4 fold), serum cholesterol (nearly 2 fold) and triglycerides (>2 fold), erythrocyte glycated hemoglobin (GHb, 3 fold) and kidney and liver lipid peroxidation (MDA levels). Treatment with AGE positively reversed the diabetic changes in the targeted parameters to levels significantly lower than those measured in the CD group and the degrees of attenuation were almost dose dependent especially with the two higher doses. AGE exhibits a dose-dependent ameliorative action on indicators of diabetes in STZ-induced diabetic rats.
- Open Access
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 455-458
Contents Vol. 14, 2005
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 455-458
Open AccessContents Vol. 14, 2005
- Open Access
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 451-452
Author Index Vol. 14, 2005
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 451-452
Open AccessAuthor Index Vol. 14, 2005
- Open Access
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 450
List of Reviewers Vol. 14, 2005
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 450
Open AccessList of Reviewers Vol. 14, 2005
- Open Access
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 449
Announcements
- 1 December 2005
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 14 (6) , 449
Open AccessAnnouncements